Sep 23, 2026 7 0
Uploaded by Patrick
Favorite
Share
More Options
13
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade_Page 1

Open in WPS to view all 13 pages